Ftse Mib
33.968,78
1,01%
DAX
18.175,21
1,01%
S&P 500
5.165,30
0,73%
NASDAQ
16.300,91
0,89%
Bitcoin
62.912,32
-1,70%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Rani Therapeutics Holdings Inc (RANI) Rani Therapeutics Holdings Inc (RANI) Notizie

Rani Therapeutics Holdings Inc

RANI
7,47
0,32 (4,48%)
Ultimo aggiornamento: 21:02:41
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
20/3/202421:05GLOBERani Therapeutics Reports Fourth Quarter and Full Year 2023..
15/3/202421:05GLOBERani Therapeutics to Report Fourth Quarter and Full Year..
05/2/202414:10EDGAR2Form 8-K - Current report
05/2/202414:00GLOBERani Therapeutics Announces Positive Topline Results from..
19/12/202322:06EDGAR2Form 8-K - Current report
19/12/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202314:05EDGAR2Form 8-K - Current report
14/12/202314:00GLOBERani Therapeutics Announces Preclinical Pharmacodynamic Data..
07/12/202323:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202314:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202314:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202322:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202322:10EDGAR2Form 8-K - Current report
08/11/202322:05GLOBERani Therapeutics Reports Third Quarter 2023 Financial..
01/11/202321:05GLOBERani Therapeutics Announces Strategic Program..
01/11/202321:04EDGAR2Form 8-K - Current report
25/10/202314:03EDGAR2Form 8-K - Current report
25/10/202314:00GLOBEThe RaniPill® Capsule, Rani Therapeutics’ Oral Delivery..
19/10/202322:05GLOBERani Therapeutics Announces Successful Oral Delivery of..
12/10/202322:05GLOBERani Therapeutics to Present Abstract on RT-102 at the 2023..
18/9/202314:00GLOBERani Therapeutics Initiates Phase 1 Study of RT-111..
07/9/202323:04EDGAR2Form 8-K - Current report
07/9/202322:05GLOBERani Therapeutics Announces Successful Drug Delivery of..
06/9/202314:00GLOBERani Therapeutics to Participate in September Investor..
11/8/202322:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/8/202322:05GLOBERani Therapeutics Reports Second Quarter 2023 Financial..
08/8/202322:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202322:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
04/8/202322:05GLOBERani Therapeutics to Participate in August Investor..
21/6/202314:00GLOBERani Therapeutics’ Presentation On Oral Delivery of PTH for..
08/6/202314:00GLOBERani Therapeutics Announces Acceptance of Late-Breaking..
05/6/202314:00GLOBERani Therapeutics and Celltrion Expand Partnership to..
01/6/202314:00GLOBERani Therapeutics to Present at the Jefferies Healthcare..
31/5/202314:00GLOBERani Therapeutics Announces Acceptance of Three Abstracts..
24/5/202314:00GLOBERani Therapeutics Appoints Kate McKinley as Chief Business..
10/5/202322:05GLOBERani Therapeutics Reports First Quarter 2023 Financial..
Apertura: 7,08 Min: 6,90 Max: 7,58
Chiusura: 7,15

La tua Cronologia

NASDAQ
RANI
Rani Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network